Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Active cell migration is critical for steady-state epithelial turnover in the gut.

Krndija D, El Marjou F, Guirao B, Richon S, Leroy O, Bellaiche Y, Hannezo E, Matic Vignjevic D.

Science. 2019 Aug 16;365(6454):705-710. doi: 10.1126/science.aau3429.

PMID:
31416964
2.

Cancer cells in the tumor core exhibit spatially coordinated migration patterns.

Staneva R, El Marjou F, Barbazan J, Krndija D, Richon S, Clark AG, Vignjevic DM.

J Cell Sci. 2019 Mar 15;132(6). pii: jcs220277. doi: 10.1242/jcs.220277.

3.

Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.

Cacheux W, Lièvre A, Richon S, Vacher S, El Alam E, Briaux A, El Botty R, Mariani P, Buecher B, Schnitzler A, Barbazan J, Roman-Roman S, Bièche I, Dangles-Marie V.

Int J Cancer. 2019 Oct 1;145(7):1852-1859. doi: 10.1002/ijc.32178. Epub 2019 Feb 18.

PMID:
30714617
4.

Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences.

Cacheux W, Tsantoulis P, Briaux A, Vacher S, Mariani P, Richard-Molard M, Buecher B, Richon S, Jeannot E, Lazartigues J, Rouleau E, Mariani O, El Alam E, Cros J, Roman-Roman S, Mitry E, Girard E, Dangles-Marie V, Lièvre A, Bièche I.

Cancer Med. 2018 May 26. doi: 10.1002/cam4.1533. [Epub ahead of print]

5.

Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma.

Cacheux W, Dangles-Marie V, Rouleau E, Lazartigues J, Girard E, Briaux A, Mariani P, Richon S, Vacher S, Buecher B, Richard-Molard M, Jeannot E, Servant N, Farkhondeh F, Mariani O, Rio-Frio T, Roman-Roman S, Mitry E, Bieche I, Lièvre A.

Oncotarget. 2017 Dec 8;9(1):464-476. doi: 10.18632/oncotarget.23066. eCollection 2018 Jan 2.

6.

Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly.

Attieh Y, Clark AG, Grass C, Richon S, Pocard M, Mariani P, Elkhatib N, Betz T, Gurchenkov B, Vignjevic DM.

J Cell Biol. 2017 Nov 6;216(11):3509-3520. doi: 10.1083/jcb.201702033. Epub 2017 Sep 20.

7.

The early pregnancy placenta foreshadows DNA methylation alterations of solid tumors.

Nordor AV, Nehar-Belaid D, Richon S, Klatzmann D, Bellet D, Dangles-Marie V, Fournier T, Aryee MJ.

Epigenetics. 2017 Sep;12(9):793-803. doi: 10.1080/15592294.2017.1342912. Epub 2017 Nov 24.

8.

Clinical value of R-spondins in triple-negative and metaplastic breast cancers.

Coussy F, Lallemand F, Vacher S, Schnitzler A, Chemlali W, Caly M, Nicolas A, Richon S, Meseure D, El Botty R, De-Plater L, Fuhrmann L, Dubois T, Roman-Roman S, Dangles-Marie V, Marangoni E, Bièche I.

Br J Cancer. 2017 Jun 6;116(12):1595-1603. doi: 10.1038/bjc.2017.131. Epub 2017 May 4.

9.

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.

Cacheux W, Rouleau E, Briaux A, Tsantoulis P, Mariani P, Richard-Molard M, Buecher B, Dangles-Marie V, Richon S, Lazartigues J, Jeannot E, Farkhondeh F, Sastre-Garau X, de La Rochefordière A, Labib A, Falcou MC, Stevens D, Roth A, Roman-Roman S, Mitry E, Bièche I, Lièvre A.

Br J Cancer. 2016 Jun 14;114(12):1387-94. doi: 10.1038/bjc.2016.144. Epub 2016 May 24.

10.

Evaluating patient-derived colorectal cancer xenografts as preclinical models by comparison with patient clinical data.

Nunes M, Vrignaud P, Vacher S, Richon S, Lièvre A, Cacheux W, Weiswald LB, Massonnet G, Chateau-Joubert S, Nicolas A, Dib C, Zhang W, Watters J, Bergstrom D, Roman-Roman S, Bièche I, Dangles-Marie V.

Cancer Res. 2015 Apr 15;75(8):1560-6. doi: 10.1158/0008-5472.CAN-14-1590. Epub 2015 Feb 24.

11.

Specific detection of type II human chorionic gonadotropin beta subunit produced by trophoblastic and neoplastic cells.

Aldaz-Carroll L, Richon S, Dangles-Marie V, Cocquebert M, Fournier T, Troalen F, Stevens D, Guery B, Hersant AM, Guibourdenche J, Nordor A, Pecking A, Bellet D.

Clin Chim Acta. 2015 Apr 15;444:92-100. doi: 10.1016/j.cca.2015.02.009. Epub 2015 Feb 12.

12.

Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.

Stimmer L, Dehay S, Nemati F, Massonnet G, Richon S, Decaudin D, Klijanienko J, Johannes L.

BMC Cancer. 2014 Dec 4;14:916. doi: 10.1186/1471-2407-14-916.

13.

Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.

Bieche I, Vacher S, Vallerand D, Richon S, Hatem R, De Plater L, Dahmani A, Némati F, Angevin E, Marangoni E, Roman-Roman S, Decaudin D, Dangles-Marie V.

BMC Cancer. 2014 Mar 13;14:178. doi: 10.1186/1471-2407-14-178.

14.

A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation.

Weiswald LB, Richon S, Massonnet G, Guinebretière JM, Vacher S, Laurendeau I, Cottu P, Marangoni E, Nemati F, Validire P, Bellet D, Bièche I, Dangles-Marie V.

Br J Cancer. 2013 Apr 30;108(8):1720-31. doi: 10.1038/bjc.2013.132. Epub 2013 Mar 28.

15.

In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy.

Weiswald LB, Guinebretière JM, Richon S, Bellet D, Saubaméa B, Dangles-Marie V.

BMC Cancer. 2010 Mar 22;10:106. doi: 10.1186/1471-2407-10-106.

16.

Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness.

Weiswald LB, Richon S, Validire P, Briffod M, Lai-Kuen R, Cordelières FP, Bertrand F, Dargere D, Massonnet G, Marangoni E, Gayet B, Pocard M, Bieche I, Poupon MF, Bellet D, Dangles-Marie V.

Br J Cancer. 2009 Aug 4;101(3):473-82. doi: 10.1038/sj.bjc.6605173. Epub 2009 Jul 14.

17.

Changes in the maternal serum concentration of proearly placenta insulin-like growth factor peptides in normal vs abnormal pregnancy.

Bruni L, Luisi S, Ferretti C, Janneau JL, Quadrifoglio M, Richon S, Dangles-Marie V, Bellet D, Petraglia F.

Am J Obstet Gynecol. 2007 Dec;197(6):606.e1-4.

PMID:
18060948
18.

Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features.

Dangles-Marie V, Pocard M, Richon S, Weiswald LB, Assayag F, Saulnier P, Judde JG, Janneau JL, Auger N, Validire P, Dutrillaux B, Praz F, Bellet D, Poupon MF.

Cancer Res. 2007 Jan 1;67(1):398-407.

19.

Impairment of lymphocyte function in head-injured rats: effects of standard and immune-enhancing diets for enteral nutrition.

Belabed L, Charrueau C, Besson V, Gupta S, Walrand S, Marchand-Verrecchia C, Richon S, Nafziger J, Plotkine M, Chaumeil JC, Cynober L, Moinard C.

Clin Nutr. 2006 Oct;25(5):832-41. Epub 2006 May 5.

PMID:
16678308
20.

A three-dimensional tumor cell defect in activating autologous CTLs is associated with inefficient antigen presentation correlated with heat shock protein-70 down-regulation.

Dangles-Marie V, Richon S, El-Behi M, Echchakir H, Dorothée G, Thiery J, Validire P, Vergnon I, Menez J, Ladjimi M, Chouaib S, Bellet D, Mami-Chouaib F.

Cancer Res. 2003 Jul 1;63(13):3682-7.

21.

Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns.

Dangles V, Lazar V, Validire P, Richon S, Wertheimer M, Laville V, Janneau JL, Barrois M, Bovin C, Poynard T, Vallancien G, Bellet D.

Br J Cancer. 2002 Apr 22;86(8):1283-9.

22.

Tumor-associated antigen human chorionic gonadotropin beta contains numerous antigenic determinants recognized by in vitro-induced CD8+ and CD4+ T lymphocytes.

Dangles V, Halberstam I, Scardino A, Choppin J, Wertheimer M, Richon S, Quelvennec E, Moirand R, Guillet JG, Kosmatopoulos K, Bellet D, Zeliszewski D.

Cancer Immunol Immunother. 2002 Feb;50(12):673-81. Epub 2001 Dec 12.

PMID:
11862419
23.

Impact of human bladder cancer cell architecture on autologous T-lymphocyte activation.

Dangles V, Validire P, Wertheimer M, Richon S, Bovin C, Zeliszewski D, Vallancien G, Bellet D.

Int J Cancer. 2002 Mar 1;98(1):51-6.

24.

MHC-dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomas.

Housseau F, Zeliszewski D, Roy M, Paradis V, Richon S, Ricour A, Bougaran J, Prapotnich D, Vallancien G, Benoit G, Desportes L, Bedossa P, Hercend T, Bidart JM, Bellet D.

Int J Cancer. 1997 May 16;71(4):585-94.

Supplemental Content

Loading ...
Support Center